Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 2
1967 1
1969 2
1970 1
1971 1
1972 2
1973 3
1974 2
1975 4
1977 2
1978 2
1979 1
1980 3
1981 2
1982 2
1983 2
1984 6
1985 1
1986 7
1987 5
1988 3
1990 12
1991 1
1992 5
1993 6
1994 4
1995 5
1996 2
1998 2
1999 3
2000 4
2001 4
2002 2
2003 3
2004 2
2005 6
2006 5
2007 4
2008 4
2009 1
2010 4
2012 3
2013 5
2014 7
2015 3
2016 5
2017 4
2018 4
2019 3
2020 5
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
COVID-19: towards controlling of a pandemic.
Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane HC, Memish Z, Oh MD, Sall AA, Schuchat A, Ungchusak K, Wieler LH; WHO Strategic and Technical Advisory Group for Infectious Hazards. Bedford J, et al. Lancet. 2020 Mar 28;395(10229):1015-1018. doi: 10.1016/S0140-6736(20)30673-5. Epub 2020 Mar 17. Lancet. 2020. PMID: 32197103 Free PMC article. No abstract available.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Ebola and healthcare worker stigma.
Wester M, Giesecke J. Wester M, et al. Scand J Public Health. 2019 Mar;47(2):99-104. doi: 10.1177/1403494817753450. Epub 2018 Jan 23. Scand J Public Health. 2019. PMID: 29359634
Living with the COVID-19 pandemic: act now with the tools we have.
Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane HC, Memish ZA, Oh MD, Sall AA, Ungchusak K, Wieler LH; WHO Strategic and Technical Advisory Group for Infectious Hazards. Bedford J, et al. Lancet. 2020 Oct 24;396(10259):1314-1316. doi: 10.1016/S0140-6736(20)32117-6. Epub 2020 Oct 8. Lancet. 2020. PMID: 33038947 Free PMC article. No abstract available.
Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.
Luciano JV, Forero CG, Cerdà-Lafont M, Peñarrubia-María MT, Fernández-Vergel R, Cuesta-Vargas AI, Ruíz JM, Rozadilla-Sacanell A, Sirvent-Alierta E, Santo-Panero P, García-Campayo J, Serrano-Blanco A, Pérez-Aranda A, Rubio-Valera M. Luciano JV, et al. Clin J Pain. 2016 Oct;32(10):829-40. doi: 10.1097/AJP.0000000000000336. Clin J Pain. 2016. PMID: 26633691
We used hierarchical cluster analysis and latent profile analysis to replicate Giesecke's classification in Spanish FM patients. The second aim was to examine whether the subgroups differed in sociodemographic characteristics, functional status, quality of life, and in dir …
We used hierarchical cluster analysis and latent profile analysis to replicate Giesecke's classification in Spanish FM patients. The …
Evidence of intense archaeal and bacterial methanotrophic activity in the Black Sea water column.
Durisch-Kaiser E, Klauser L, Wehrli B, Schubert C. Durisch-Kaiser E, et al. Appl Environ Microbiol. 2005 Dec;71(12):8099-106. doi: 10.1128/AEM.71.12.8099-8106.2005. Appl Environ Microbiol. 2005. PMID: 16332791 Free PMC article.
ANME-1 and ANME-2 appear as single cells in anoxicwater, compared to the sediment, where they may form cell aggregates with sulfate-reducing bacteria (A. Boetius, K. Ravenschlag, C. J. Schubert, D. Rickert, F. Widdel, A. Giesecke, R. Amann, B. B. Jorgensen, U. Witte …
ANME-1 and ANME-2 appear as single cells in anoxicwater, compared to the sediment, where they may form cell aggregates with sulfate-reducing …
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance.
Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, Wappenschmidt B, Hübbel V, Maringa M, Reichstein-Gnielinski S, Hahnen E, Bartram CR, Dikow N, Schott S, Speiser D, Horn D, Fallenberg EM, Kiechle M, Quante AS, Vesper AS, Fehm T, Mundhenke C, Arnold N, Leinert E, Just W, Siebers-Renelt U, Weigel S, Gehrig A, Wöckel A, Schlegelberger B, Pertschy S, Kast K, Wimberger P, Briest S, Loeffler M, Bick U, Schmutzler RK; German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). Engel C, et al. Int J Cancer. 2020 Feb 15;146(4):999-1009. doi: 10.1002/ijc.32396. Epub 2019 May 22. Int J Cancer. 2020. PMID: 31081934 Free article.
167 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page